|
ETFB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.672970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.235800E-02 |
| Normal-vs-Stage2 |
1.427570E-02 |
| Normal-vs-Stage3 |
1.417610E-01 |
| Normal-vs-Stage4 |
4.278900E-03 |
| Stage1-vs-Stage2 |
7.169100E-04 |
| Stage1-vs-Stage3 |
9.923600E-01 |
| Stage1-vs-Stage4 |
9.104400E-02 |
| Stage2-vs-Stage3 |
1.182120E-03 |
| Stage2-vs-Stage4 |
5.99279999999869E-05 |
| Stage3-vs-Stage4 |
1.432000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.187820E-01 |
| Normal-vs-AfricanAmerican |
9.260400E-02 |
| Normal-vs-Asian |
4.783600E-02 |
| Caucasian-vs-AfricanAmerican |
5.575000E-01 |
| Caucasian-vs-Asian |
3.770800E-01 |
| AfricanAmerican-vs-Asian |
9.326000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.621400E-01 |
| Normal-vs-Female |
1.186050E-01 |
| Male-vs-Female |
5.101400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.866440E-01 |
| Normal-vs-Age(41-60Yrs) |
2.258600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.276200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.698200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.724000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.884400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.532800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.798200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.933200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.816600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.627900E-02 |
| Classical-VS-Follicular |
2.40629999999076E-05 |
| Classical-VS-Other |
6.338000E-01 |
| Classical-VS-Normal |
1.842480E-02 |
| Tall-VS-Follicular |
4.62020000036034E-07 |
| Tall-VS-Other |
3.126000E-01 |
| Tall-VS-Normal |
1.367500E-04 |
| Follicular-VS-Other |
3.372000E-01 |
| Follicular-VS-Normal |
2.413900E-02 |
| Other-VS-Normal |
8.685400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.261000E-01 |
| Normal-vs-N1 |
4.501200E-03 |
| N0-vs-N1 |
1.017410E-03 |
|
|
